S&P Upgrades ICU Medical to BB as Leverage Falls and Cash Flow Strengthens
S&P Global Ratings raised ICU Medical Inc.'s corporate credit rating to BB from BB- after the infusion-therapy supplier showed meaningful deleveraging and stronger free operating cash flow. Key drivers included the companys use of proceeds from a 2025 divestiture and additional cash flow-driven debt repayments in the second quarter of 2026. S&Ps …